This product has the characteristics of promoting mucus elimination and dissolving secretions. It can promote the elimination of viscous secretions in the respiratory tract and reduce mucus retention, thereby significantly promoting expectoration and improving respiratory conditions. When treated with this product, the patient's mucus secretion can return to normal. Cough and sputum volume are usually significantly reduced, and the surfactant of the respiratory mucosa can thus play its normal protective function. Since this drug has good tolerance, it can be used for a long time. The toxicity index of ambroxol in acute toxicity tests is very low. Ambroxol is not mutagenic (Ames and micronucleus tests). Carcinogenicity studies on mice and rats have shown that ambroxol is not carcinogenic.

Prostaglandin synthase inhibitor, with antipyretic, analgesic and anti-inflammatory effects

Adrenergic receptor agonists have a selective vasoconstriction effect, which can relieve congestion and swelling of the nasopharyngeal mucosa and relieve nasal congestion symptoms.

This product is a non-steroidal antipyretic, analgesic and anti-inflammatory drug. Its mechanism of action is to inhibit the synthesis of prostaglandins, thereby exerting antipyretic, analgesic and anti-inflammatory effects.

Reduce serum cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL-C) and increase high-density lipoprotein (HDL-C), reduce whole blood and plasma viscosity

Reduce serum cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL-C) and increase high-density lipoprotein (HDL-C), reduce whole blood and plasma viscosity

Reduce serum cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL-C) and increase high-density lipoprotein (HDL-C), reduce whole blood and plasma viscosity

Reduce serum cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL-C) and increase high-density lipoprotein (HDL-C), reduce whole blood and plasma viscosity

Reduce serum cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL-C) and increase high-density lipoprotein (HDL-C), reduce whole blood and plasma viscosity

This product is a broad-spectrum antiviral drug. Its mechanism of action is mainly to inhibit inosine dehydrogenase, block the conversion of inosine-phosphate to xanthine-phosphate, thereby inhibiting nucleic acid synthesis and preventing viral replication.